GL1X · GenesisL1 explorer

MolNFT v1 · #16195 · protein

Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes

1NRO · Alpha-thrombin (small subunit): “Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and…”. X-ray diffraction, 2 pockets (best druggability 0.50). MolNFT v1 #16195 on GenesisL1…

PDB
1NRO
Type
protein
Length
296 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-thrombin (small subunit); Alpha-thrombin (large subunit); Receptor based peptide nrp
EC
3.4.21.5
UniProt
P00734, P25116
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 3 distinct chains · 12% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAlpha-thrombin (small subunit) (EC 3.4.21.5)protein2938% helix, 0% strandP00734
HAlpha-thrombin (large subunit) (EC 3.4.21.5)protein25710% helix, 26% strandP00734
RReceptor based peptide nrpprotein100% helix, 0% strandP25116

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11620.500.7816empty
2510.320.7713empty

Interfaces

2 interfaces between chains.

  • L–H · 1075 Ų buried · 19 hydrogen bonds · protein-protein
  • H–R · 594 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1NRO · Crystallographic structures of thrombin complexed with thrombin receptor peptides… · the same entry in another collection · chain L against L, TM-score 1.00
  • P25116 · AlphaFold monomer V2.0 prediction for proteinase-activated receptor 1 (P25116) · a predicted model of the same protein · chain R against A, TM-score 0.34

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.